Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More

Invitae: Roxi Wen, Katherine Stueland 

Roxi Wen has been appointed as CFO of Invitae, effective June 21. She will replace Shelly Guyer, who will focus on the company's environment, social, and governance efforts. Wen joins Invitae from Mozilla, where she has been CFO. Prior to that, she was CFO at Elo Touch Solutions, and before that, VP of finance at FleetPride. Previously, she was CFO at General Electric Critical Power. Wen holds a bachelor of economics from Xiamen University and an MBA from the University of Minnesota. 

Katherine Stueland will step down as chief commercial officer of Invitae, effective June 18, to become CEO at another company.


Personal Genome Diagnostics: Brent Dial 

Personal Genome Diagnostics has appointed Brent Dial as its CFO. He previously served as principal at Chordata Ventures. Prior to that, he was CFO of Anheuser-Busch's high end division. He also held positions at JP Morgan Chase, Deutsche Bank Securities, and TCOM. Dial holds an MBA in corporate finance from the University of Pennsylvania’s Wharton School and is a graduate of the United States Military Academy. 


 Oxford Nanopore Technologies: Justin O'Grady 

Justin O'Grady has joined Oxford Nanopore Technologies as senior director of translational applications. Previously, he was a senior lecturer in medical microbiology at the University of East Anglia, and before that, a group leader at the Quadram Institute. He holds Ph.D., M.Sc., and B.Sc. degrees in microbiology from the National University of Ireland, Galway.


Pacific Biosciences: Neil Ward 

Pacific Biosciences has appointed Neil Ward as VP and general manager for Europe, the Middle East, and Africa.

Ward comes to PacBio from Illumina, where he was senior sales director for Northern Europe. Prior to his 13 years at Illumina, he held bioinformatics and sales roles at Agilent Technologies, Silicon Genetics, Oxford Biomedica, and Celltech. Ward holds a master's degree in bioinformatics from the University of Manchester. 


For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.